EORTC-EANO Conference 2011: Trends in Central Nervous System Malignancies, Bucharest, Romania, 25-26 March 2011
10 Nov 2010
Following the success of the first EORTC-EANO Conference in 2009 in Hungary, we are extremely proud to announce on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group and the European Association of Neuro-Oncology (EANO), the second in the biennial series of EORTC-EANO Conferences: Trends in Central Nervous System Malignancies.
The main focus of the joint EORTC-EANO Conferences is to progress the neuro-oncology field, accelerate the translation of cutting edge discovery at the clinical level, and further promote international scientific cooperation, debate and exchange.
Adopting a highly multidisciplinary approach, each EORTC-EANO Conference will aim to draw an attendance of neurosurgeons, neurologists, neuropathologists, medical oncologists, and radiation oncologists sharing the common goal of advancing the management, treatment and care of patients with central nervous system tumors, including gliomas, brain and spine metastatic disease, meningioma, CNS lymphoma and primary spinal cord tumors.
Through a series of plenary sessions, workshops and breakout sessions, Trends in Central Nervous System Malignancies will provide a rigorous review of novel therapies, agents and combination strategies, as well as report on the very latest findings in basic and clinical research.
Lastly, but by no means least, our host city Bucharest, known for its wide, tree-lined boulevards, glorious Belle Époque buildings and a reputation for the high life, will provide yet further reason for joining us for the second EORTC-EANO Conference.
We look forward to welcoming you all for what promises to be an outstanding educational event: Trends in Central Nervous System Malignancies, 25-26 March 2011.
Martin J. van den Bent Wolfgang Grisold
EORTC EANO
Related News
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
Interview of ROSC Chair, Joost Vaerhoeff
28 Apr 2026